Subcutaneous Implantable Cardioverter‐Defibrillator in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: A Transatlantic Experience
Journal of the American Heart Association - United Kingdom
doi 10.1161/jaha.118.008782
Full Text
Open PDFAbstract
Available in full text
Date
November 6, 2018
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)